載入...
Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
Inflammatory bowel disease (IBD), in particular Crohn’s disease refractory to conventional therapy, fistulizing Crohn’s disease and chronic active ulcerative colitis, generally respond well to anti-tumor necrosis factor (TNF) therapy. However, serious side effects do occur, necessitating careful mon...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The WJG Press and Baishideng
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2678575/ https://ncbi.nlm.nih.gov/pubmed/19418577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.2067 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|